Focus Partners Wealth’s BeOne Medicines Ltd ONC Stock Holding History

Focus Partners Wealth’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$863K	Sell	3,029 -303	-9%	-$89.3K	﹤0.01%	1705
2026 Q1	$990K	Buy	3,332 +836	+33%	+$271K	﹤0.01%	1627
2025 Q4	$758K	Sell	2,496 -73	-3%	-$23.9K	﹤0.01%	1755
2025 Q3	$842K	Buy	2,569 +1,263	+97%	+$384K	﹤0.01%	1359
2025 Q2	$316K	Buy	1,306 +159	+14%	+$39K	﹤0.01%	1653
2025 Q1	$312K	Sell	1,147 -106	-8%	-$24.8K	﹤0.01%	1553
2024 Q4	$231K	Sell	1,253 -9,182	-88%	-$1.88M	﹤0.01%	1666
2024 Q3	$2.34M	Sell	10,435 -76	-0.7%	-$13.7K	0.01%	738
2024 Q2	$1.5M	Buy	10,511 +300	+3%	+$46.2K	0.01%	708
2024 Q1	$1.6M	Buy	10,211 +23	+0.2%	+$3.7K	0.01%	523
2023 Q4	$1.84M	Buy	+10,188	New	+$1.84M	0.02%	366

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Focus Partners Wealth's ONC Position: Q2 2026 in Review

Focus Partners Wealth reduced its BeOne Medicines Ltd (ONC) stake by 9.1% in Q2 2026, selling an estimated $89.3K and leaving 3,029 shares worth $863K. The position accounts for ﹤0.01% of the portfolio, ranked #1705.

Focus Partners Wealth first reported a position in ONC in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.34M in Q3 2024. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Focus Partners Wealth held 3,029 shares of BeOne Medicines Ltd worth $863K as of Q2 2026.
Focus Partners Wealth sold 303 BeOne Medicines Ltd shares in Q2 2026, an estimated $89.3K.
BeOne Medicines Ltd made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #1705 holding.
Focus Partners Wealth first reported a position in BeOne Medicines Ltd in Q4 2023 and has held it in 11 quarters since.
Focus Partners Wealth's BeOne Medicines Ltd position peaked at $2.34M in Q3 2024.
283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.